中文别名:
奥利司他杂质A;(3S,4S)-3-己基-4-[(2R)-2-羟基十三烷基]-2-氧杂环丁酮;奥利斯特杂质A;5-(2-氯苯基)-7-乙基-1,3-二氢-2H-噻吩并[2,3-E][1,4]二氮杂卓-2-酮;奥利司他USP相关化合物 A;奥利司他相关物质A USP标准品;奥利司他相关物质A;奥利司他USP RC A;
英文别名:
(3S,4S)-3-Hexyl-4-((R)-2-hydroxytridecyl)oxetan-2-one;(3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone;(3S,4S)-3-HEXYL-4-[(R)-2-(HYDROXYTRIDECYL)]OXETAN-2-ONE;(3S,4S)-3-Hexyl-4-((R)-2-hydroxytridecyl)-oxetan-2-one;(3S,4S)-3-hexyl-4-[(2R)-2-hydroxytridecyl]oxetan-2-one;Orlistat USP RC A;Orlistat Related CoMpound A;Orlistat USP Related Compound A;(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone;2-Oxetanone,3-hexyl-4-[(2R)-2-hydroxytridecyl]-, (3S,4S)-;[3S-[3α,4β(S*)]]-3-Hexyl-4-(2-hydroxytridecyl)-2-oxetanone;Orlistat Related Compound A (25 mg) ((3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone);(3S,4S)-3-hexyl-4-((R)-2-hydroxy tridecyl)-2-oxetanone;BJV8QU12YI;DTXSID90146800;(2R,3S,4S)-3-Hexyl-4-(2-hydroxy-tridecyl)-oxetan-2-one;104872-06-2;EC 418-650-2;Q27274709;2-Oxetanone, 3-hexyl-4-((2R)-2-hydroxytridecyl)-, (3S,4S)-;NS00002742;SCHEMBL712201;3-Hexyl-4-((R)-2-hydroxytridecyl)-2-oxetanone, (3S,4S)-;RSOUWOFYULUWNE-HKBOAZHASA-N;UNII-BJV8QU12YI;(3S,4S)-3-Hexyl-4-((R)-2-hydroxytridecyl)-2-oxetanone;(3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone; 2-Oxetanone, 3-hexyl-4-(2-hydroxytridecyl)-, [3S-[3a,4ss(S*)]]-; Orlistat Related Compound A (USP);
Inchi:
1S/C22H42O3/c1-3-5-7-9-10-11-12-13-14-16-19(23)18-21-20(22(24)25-21)17-15-8-6-4-2/h19-21,23H,3-18H2,1-2H3/t19-,20+,21+/m1/s1